State Ledger
Company profile

Cadrenal Therapeutics, Inc. CIK 1937993

Ticker
CVKD (Nasdaq)
Industry
Pharmaceutical Preparations
Headquarters
Ponte Vedra, FL 32082
Fiscal year end
2025 (FY)
Market Data
Close
$0.92
Change
-$0.00
Change %
-0.53%
Volume
389

CVKD · trading date Oct 9, 2026 · previous close $0.92 · source: Alpaca (IEX feed, not consolidated full-market data).

Key Financials
Revenue
—
Net income
-$13.24M
Total assets
$4.33M
Total liabilities
$1.59M
Stockholders' equity
$2.74M
Cash & equivalents
$4.01M
Operating income
-$13.46M
Operating cash flow
-$12.60M
Capital expenditures
$5.1K

Fiscal year 2025, via 10-K filed 2026-03-31. A dash means this figure wasn't reported in the source filing under a field State Ledger recognizes - not that the value is zero.

Financial Performance
Operating margin
—
Net margin
—
Free cash flow
-$12.61M
Free cash flow margin
—
Liabilities / assets
36.7%
Equity / assets
63.3%
CapEx / revenue
—
Operating cash flow / net income
0.95×

Derived from the fiscal year 2025 figures above. These metrics are mathematical calculations and do not represent a rating or assessment of the company.

Financial History
Fiscal yearRevenueNet incomeAssetsLiabilitiesEquity
2025 — -$13.24M $4.33M $1.59M $2.74M
2024 — -$10.65M $10.12M $2.68M $7.44M
2023 — -$8.36M $8.52M $826.9K $7.69M
2022 — — $778.2K $6.33M -$5.55M
Company Details
SIC code
2834
State of incorporation
DE
Active filer
Yes
Most recent SEC filing
Form S-8
2026-09-03
Financials filed via
Form 10-K
filed 2026-03-31

"Most recent SEC filing" may differ from the filing used for the financial figures above.

Location
Ponte Vedra, FL 32082
822 A1A NORTH
Data & Methodology

SEC EDGAR submissions API (identity, collected Sep 19, 2026, 15:11 UTC) and SEC XBRL Company Facts API (financials, collected Sep 26, 2026, 15:27 UTC) · figures as originally filed, not restated · a dash always means a value wasn't reported, never a real zero.

← Back to Florida — Public Companies